GELS
Gelteq Ltd.
NASDAQ · Healthcare · Drug Manufacturers - Specialty & Generic · AU
$0.56
−3.07%Price chart
Aug 19Aug 24Aug 27Sep 1Sep 4Sep 10Sep 15Sep 18
Key dataSep 18, 2026
Open$0.58
From 52W high−63.27%
Volume67078.00
Market cap$6.28M
P/E (TTM)—
P/S (TTM)53.4x
Div yield—
Key dataSep 18, 2026
Open
$0.58
From 52W high
−63.27%
Volume
67078.00
Market cap
$6.28M
ValuationView details →
P/E (Fwd)
—
EV/EBITDA
−4.0x
P/E (TTM)
—
RSI (14)
44.8
MomentumView details →
1D Return
−3.07%
YTD Return
−29.01%
SummaryUpdated Dec 1, 2025
Gelteq Limited (NASDAQ:GELS) is an Australian pharmaceutical technology company founded in 2017 and headquartered in Caulfield, Australia. The company specializes in developing and commercializing innovative gel-based delivery systems for pharmaceutical and consumer health products across both human and animal applications. Since its incorporation, Gelteq has positioned itself as a white-label solutions provider in the drug delivery space, focusing on creating proprietary gel formulations that can enhance the effectiveness and user experience of various therapeutic and wellness products.
Similar companies
Latest newsMore news →